172 related articles for article (PubMed ID: 7636666)
1. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
Flynn PM; Cunningham CK; Kerkering T; San Jorge AR; Peters VB; Pitel PA; Harris J; Gilbert G; Castagnaro L; Robinson P
J Pediatr; 1995 Aug; 127(2):322-8. PubMed ID: 7636666
[TBL] [Abstract][Full Text] [Related]
2. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group.
Hoppe JE
Pediatr Infect Dis J; 1997 Mar; 16(3):288-93. PubMed ID: 9076817
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
Goins RA; Ascher D; Waecker N; Arnold J; Moorefield E
Pediatr Infect Dis J; 2002 Dec; 21(12):1165-7. PubMed ID: 12506950
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole versus nystatin in the treatment of oral candidosis.
Blomgren J; Berggren U; Jontell M
Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
[TBL] [Abstract][Full Text] [Related]
6. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
Mukherjee PK; Chen H; Patton LL; Evans S; Lee A; Kumwenda J; Hakim J; Masheto G; Sawe F; Pho MT; Freedberg KA; Shiboski CH; Ghannoum MA; Salata RA;
AIDS; 2017 Jan; 31(1):81-88. PubMed ID: 27677161
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
[TBL] [Abstract][Full Text] [Related]
8. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.
Lyu X; Zhao C; Yan ZM; Hua H
Drug Des Devel Ther; 2016; 10():1161-71. PubMed ID: 27042008
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
Young GA; Bosly A; Gibbs DL; Durrant S
Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
[TBL] [Abstract][Full Text] [Related]
12. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Fan S; Liu X; Wu C; Xu L; Li J
Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
[TBL] [Abstract][Full Text] [Related]
13. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
Taillandier J; Esnault Y; Alemanni M
Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
[TBL] [Abstract][Full Text] [Related]
14. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
Ninane J
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):330-7. PubMed ID: 7794307
[TBL] [Abstract][Full Text] [Related]
15. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.
Meunier F; Aoun M; Gerard M
Rev Infect Dis; 1990; 12 Suppl 3():S364-8. PubMed ID: 2184513
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Hernández-Sampelayo T
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients.
Ruskin JD; Wood RP; Bailey MR; Whitmore CK; Shaw BW
Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):567-71. PubMed ID: 1437059
[TBL] [Abstract][Full Text] [Related]
18. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].
Marchisio P; Principi N
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):338-40. PubMed ID: 8070442
[TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.
Marriott DJ; Jones PD; Hoy JF; Speed BR; Harkness JL
Med J Aust; 1993 Mar; 158(5):312-6. PubMed ID: 8097273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
